Guidelines for treatment of atopic eczema (atopic dermatitis) part I. - Wikidata - wikimedia - TriplyDB

Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

http://www.wikidata.org/entity/Q50927518

about

Atopic dermatitis: natural history, diagnosis, and treatment Oral H1 antihistamines as ‘add-on’ therapy to topical treatment for eczema Emollients and moisturisers for eczema Complementary and alternative medicine treatments for atopic eczema Stigmatization and self-perception in children with atopic dermatitis S2k guideline on diagnosis and treatment of atopic dermatitis — short version A review on the role of moisturizers for atopic dermatitis A Comprehensive Review of the Treatment of Atopic Eczema Child with atopic dermatitis Atopic dermatitis and skin allergies - update and outlook Systemic therapy for atopic dermatitis Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis The diagnosis and graded therapy of atopic dermatitis Consensus Conference on Clinical Management of pediatric Atopic Dermatitis Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants Psoriasis and Atopic Dermatitis.The solid-state fermentation of Artemisia capillaris leaves with Ganoderma lucidum enhances the anti-inflammatory effects in a model of atopic dermatitis.Particular characteristics of atopic eczema in tropical environments. The Tropical Environment Control for Chronic Eczema and Molecular Assessment (TECCEMA) cohort study.Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy Translation and validation of Portuguese of a questionnaire for evaluation of psychosomatic symptoms in adults with atopic dermatitis Prehydration is effective for rapid control of recalcitrant atopic dermatitis Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.Target-oriented therapy: Emerging drugs for atopic dermatitis.Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis.Mapping systematic reviews on atopic eczema--an essential resource for dermatology professionals and researchers.Efficacy and Tolerability of Steroid-Free, Over-the-Counter Treatment Formulations in Infants and Children With Atopic Dermatitis Disease awareness and management behavior of patients with atopic dermatitis: a questionnaire survey of 313 patients.Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.Alpine climate treatment of atopic dermatitis: a systematic review.Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches Chitosan Coated Textiles May Improve Atopic Dermatitis Severity by Modulating Skin Staphylococcal Profile: A Randomized Controlled Trial Effects of a New Emollient-Based Treatment on Skin Microflora Balance and Barrier Function in Children with Mild Atopic Dermatitis Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology.Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment.Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment.Effects of Angelicae dahuricae Radix on 2, 4-Dinitrochlorobenzene-Induced Atopic Dermatitis-Like Skin Lesions in mice model Emollients and moisturisers for eczema: abridged Cochrane systematic review including GRADE assessments.Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis.Skin-protective effects of a zinc oxide-functionalized textile and its relevance for atopic dermatitis

P2860

Q21284712-EA405F26-CDD3-4357-8758-720E402D5A97 Q24185954-002E350B-D74A-4B47-9B10-DB1D2CEC4113 Q24186075-0E7AEF2B-09EF-4F1E-BDDA-07EEE6B92344 Q24201373-4C37BB16-3136-4920-B0E8-F6FFD04728A0 Q26738669-835BB4BE-7947-437B-AE7B-912657202D58 Q26744978-BF524096-4F41-485C-BDD9-CFCF44A89763 Q26747634-C597E0C6-79E0-4DB8-B0D0-615845A410EA Q26765975-EACABC7F-6702-4F2A-B842-FF4E16668BB3 Q26830792-39059218-1E80-4484-BBAB-3AFB6BDD6470 Q26851924-67D2640E-369C-4C49-8349-95AD550FA57D Q27005835-66C1D2B7-8AB6-40D6-BF84-DE2FA583BC58 Q27024192-AE7CE436-B88F-4CD7-B1DC-D33261B1A19D Q27025032-09DF553E-066C-498C-9E35-02FA325E5FA8 Q28071974-83072301-4211-4AB4-AF7C-8063909CC3AB Q28086973-CB0007B8-6CCE-4122-9D29-51A4AD8E8F9A Q30238648-4F09B9A2-6F91-47E5-8271-61944A9AAC14 Q33599021-323D90DA-B770-4055-9833-71F5F2A6E554 Q33675713-B0B66A44-D45E-4877-A576-7C0832EEC393 Q33713754-5DEC9954-118D-4866-83D1-3ED15EB91289 Q34140507-0840F378-A246-45FA-AC5D-98D728EE8572 Q34246935-4CDCA3E0-FC47-4AB0-8174-AA6B001BC625 Q34388802-C1347712-12F4-4151-95E3-26361E209D59 Q34510687-91E3E481-A048-4A4F-9E0E-FFE80C09FE1E Q34518989-1BF29C39-A083-4931-912E-6FF07D705F66 Q34625848-F547914E-9D7F-48A6-9ED7-18C459DE199D Q35054228-84762697-11C7-4379-9F70-A439A48742B6 Q35069948-47D8D5E5-67CC-46C5-ABF9-22FF162B33E8 Q35077866-B8407119-F878-409B-B807-BF57F916D64E Q35226555-E33DE5AF-1DD4-4FB7-B27D-A2DCB48281D3 Q35539576-FE105D5C-2CA9-4F41-B663-D0F4D397EEFA Q35603170-BF74B242-AE8D-4BEF-B253-6104661808E6 Q35855543-784DA7C1-87CD-4976-9547-EF0E5050EBE3 Q35965477-743EDEFA-02F3-4564-9509-06DB2FE39B08 Q36048469-AA192537-1AB0-42B6-884D-29A4FEFED0E4 Q36214247-CEB7CA0F-B651-4F3C-9C60-93295DCA290F Q36214254-6A150958-BE2D-4B67-AF18-F56401890606 Q36273350-1D2490C6-E81D-4295-9A73-63B9CC5F4658 Q36354045-75D95604-745E-4E32-A467-3701062A78B3 Q36760937-BB8742BE-BAFD-43E2-AB82-2557291F257E Q36851352-64570C47-B971-457E-A328-DB4932DBB349

P2860

Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

http://www.wikidata.org/entity/Q50927518

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

@en

Guidelines for treatment of atopic eczema

@nl

type

label

Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

@en

Guidelines for treatment of atopic eczema

@nl

prefLabel

Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

@en

Guidelines for treatment of atopic eczema

@nl

P1433

Q50927518-AF103D63-C3E5-4C52-AD26-4EBA9F2E1ED9

P1476

Q50927518-6C625A34-E9A6-430C-BF16-F41204D56E6E

P2093

Q50927518-0F7A2788-C84F-4C95-BC00-F88A52333356

Q50927518-1BDC013F-F4FC-4D7B-9C96-8A9F66D3F07D

Q50927518-25052D80-1CF9-4929-A257-8DBD116A586D

Q50927518-341CDC65-5AE6-4EA3-A502-98054D05A600

Q50927518-5535951F-139E-4C12-9656-5368E17A28EE

Q50927518-6879F38F-DB47-429C-86DD-ECCA72E71715

Q50927518-6A76650A-A60D-46A7-8DF7-5FF5552AD314

Q50927518-6C4498E2-513C-4BAA-A6F5-1D371BE320D1

Q50927518-74CB3D97-3287-4E60-9CC8-888683E16805

Q50927518-84EC3173-3C48-493E-9942-CF5C935316DA

P2860

Q50927518-0601764E-F661-4888-A21A-105ECCA6CD35

Q50927518-06561FDF-D5A0-4D45-943A-BD3C20ABF8F7

Q50927518-0BD90831-16CD-4A17-A935-2243BFD2E3C7

Q50927518-0BEE0987-FA49-4C49-93DB-FF1E3CE22E00

Q50927518-1124DC29-E7B2-4039-9808-D9472AC56962

Q50927518-115297F5-D41F-40DD-BB3B-256BF9E2BBF0

Q50927518-127CB7F9-D97C-4B73-A374-834719954097

Q50927518-137D1D2B-6550-43AE-A709-DB059EF827F3

Q50927518-1808E6CD-7493-4471-9C33-292B5ACB6B45

Q50927518-19CF8D8D-5797-45E3-8EED-B4A80B11B66D

P304

Q50927518-45133664-F320-4845-8CAA-0B70A12F62B0

P31

Q50927518-54E7B011-9320-4F0D-88FB-9BB929A0780E

P356

Q50927518-CD4BC332-4EAF-4870-9921-B1F5F14B4D5A

P433

Q50927518-E5CF4F5E-5BDE-46E7-A1E3-B6CA3EE5BFE6

P478

Q50927518-102B0F44-0743-4F2A-AF74-86D0DC4156AE

P50

Q50927518-6A5BBF23-E49F-4CA8-8DA0-8FC70FEB84F8

Q50927518-E7CFADEB-00AE-4DD5-BDD3-62F0E140267E

P577

Q50927518-1893BD63-9D7A-4E37-A277-0C4331750540

P698

Q50927518-C8CAC471-0E20-431A-B950-7D15D7A99844

P356

J.1468-3083.2012.04635.X

P1433

Journal of the European Academy of Dermatology and Venereology

P1476

Guidelines for treatment of atopic eczema (atopic dermatitis) part I

@en

P2093

A Alomar

http://www.w3.org/2001/XMLSchema#string

A Fink-Wagner

http://www.w3.org/2001/XMLSchema#string

A P Oranje

http://www.w3.org/2001/XMLSchema#string

A Taïeb

http://www.w3.org/2001/XMLSchema#string

A Wollenberg

http://www.w3.org/2001/XMLSchema#string

C Gelmetti

http://www.w3.org/2001/XMLSchema#string

D Simon

http://www.w3.org/2001/XMLSchema#string

European Academy of Dermatology and Venereology (EADV)

http://www.w3.org/2001/XMLSchema#string

European Dermatology Forum (EDF)

http://www.w3.org/2001/XMLSchema#string

European Federation of Allergy (EFA)

http://www.w3.org/2001/XMLSchema#string

P2860

Factors associated with the development of peanut allergy in childhood

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin.

Flucloxacillin in the treatment of atopic dermatitis.

Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema - a blinded, randomized, placebo-controlled, crossover trial.

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group.

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force.

Airborne and dietary allergens in atopic eczema: a comprehensive review of diagnostic tests.

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.

The role of the atopy patch test (APT) in diagnosis of food allergy in infants and children with atopic dermatitis.

P304

1045-1060

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-3083.2012.04635.X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22805051

http://www.w3.org/2001/XMLSchema#string